The Medicines and Healthcare products Regulatory Agency (MHRA) has announced a new Community of Practice for Digital Mental Health Technologies, according to an announcement published on its official blog. The forum is intended to strengthen regulatory understanding and provide practical support to developers in a fast-growing part of UK medtech.
The MHRA said the community would bring together developers, clinicians, researchers, commissioners and regulatory specialists to share best practice. It is meant to help innovators navigate regulatory expectations, improve compliance and bring safe, effective digital mental health solutions into clinical use more quickly.
Shared learning and earlier compliance
The announcement points to rising demand for clarity on evidence requirements, post-market responsibilities and the evolving regulatory landscape for software-based and AI-enabled mental health tools. The community’s stated objectives include helping developers interpret regulatory requirements and embed compliance earlier in product design.
It also aims to identify common challenges, especially for small and medium-sized enterprises entering the mental health space; share real-world experience from organisations already working through regulatory pathways; and strengthen dialogue between industry and regulators on safety, performance and evidence expectations.
Survey to set initial priorities
To shape the community’s initial priorities, the MHRA has opened a survey for digital mental health technology developers and stakeholders across the medtech ecosystem. The survey asks about current regulatory challenges, where clearer guidance is needed and opportunities to improve compliance support.
The MHRA is encouraging broad participation so that the community reflects real-world needs rather than top-down assumptions. Developers are being asked to complete the survey and share it within their organisations. A strong response, the agency suggests, will help the community deliver practical support and accelerate safe, effective innovation for patients.
